The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
Indiana University School of Medicine, Indianapolis, 46202, USA. nchalasa@iupui.edu
Naga
N
Chalasani
Zobair
Z
Younossi
Joel E
JE
Lavine
Anna Mae
AM
Diehl
Elizabeth M
EM
Brunt
Kenneth
K
Cusi
Michael
M
Charlton
Arun J
AJ
Sanyal
D000428:Alcohol Drinking / Q000009:adverse effects; D050110:Bariatric Surgery; D001706:Biopsy; D002648:Child; D019468:Disease Management; D005234:Fatty Liver / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D005235:Fatty Liver, Alcoholic / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D015994:Incidence; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000628:therapy; D008403:Mass Screening; D065626:Non-alcoholic Fatty Liver Disease; D015995:Prevalence; D012307:Risk Factors; D040242:Risk Reduction Behavior; D012720:Severity of Illness Index; D014481:United States / Q000453:epidemiology; D014810:Vitamin E / Q000008:administration & dosage; D015431:Weight Loss
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents; D014810:Vitamin E